Anthony D Bruno
CIK 1374180 · Exec. V.P., Corp. Development · last filed 2024-12-13
Anthony D Bruno is an Exec. V.P., Corp. Development who has filed 22 SEC Form 4 insider transactions across 4 companies since 2009. The most recent filing, for VYNE, was dated Dec 13, 2024.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
4
22
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VYNE | Director | — | $0.65 | — | $0 | 5 | 2024-12-13 |
| VYNE Therapeutics Inc. (MNLO) Delisted | Director | 135,056 | — | — | $0 | 4 | 2020-08-05 |
| Foamix Pharmaceuticals Ltd. (FOMX) Delisted | Director | 75,007 | — | — | $0 | 2 | 2020-03-03 |
| Warner Chilcott plc (WCRX) Delisted | Exec. V.P., Corp. Development | 970,774 | — | — | $0 | 1 | 2009-01-22 |
Recent Filings
22 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-12-13 | VYNE | Grant (A) | — | $0 | EDGAR |
| 2024-01-03 | VYNE | Grant (A) | — | $0 | EDGAR |
| 2023-12-15 | VYNE | Grant (A) | — | $0 | EDGAR |
| 2022-08-12 | VYNE | Grant (A) | — | $0 | EDGAR |
| 2021-07-20 | VYNE | Grant (A) | — | $0 | EDGAR |
| 2020-08-05 | VYNE Therapeutics Inc. (MNLO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-04-07 | VYNE Therapeutics Inc. (MNLO) Delisted | Grant (A) | +90,623 | $0 | EDGAR |
| 2020-03-23 | VYNE Therapeutics Inc. (MNLO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-03-11 | — | Disp (D) | −75,007 | $0 | |
| 2020-03-11 | VYNE Therapeutics Inc. (MNLO) Delisted | Grant (A) | +44,433 | $0 | EDGAR |